Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Kim, Tae Dong ^a   Oh, Sangphil ^a   Shin, Sook ^a   Janknecht, Ralf ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOXORUBICIN; HISTONE DEMETHYLASE; LUCIFERASE; PROTEIN JMJD2D; PROTEIN KDM4D; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG; KDM4D PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CATALYSIS; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN HCT116; CELL SURVIVAL; COLON CANCER; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS INHIBITION; OSTEOSARCOMA CELL; PLASMID; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; TUMOR SUPPRESSOR GENE; WILD TYPE; CELL LINE; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; OSTEOSARCOMA;

APOPTOSIS; CELL LINE; CELL PROLIFERATION; DOXORUBICIN; GENE EXPRESSION; HCT116 CELLS; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; OSTEOSARCOMA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84859725611     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034618     Document Type: Article

References (69)

1. Klose RJ, Kallin EM, Zhang Y, (2006) JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet 7: 715-727.
2. Shi Y, Whetstine JR, (2007) Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 25: 1-14.
3. Cloos PA, Christensen J, Agger K, Helin K, (2008) Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev 22: 1115-1140.
4. Chi P, Allis CD, Wang GG, (2010) Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10: 457-469.
5. Katoh M, Katoh M, (2004) Identification and characterization of JMJD2 family genes in silico. Int J Oncol 24: 1623-1628.
6. Yap KL, Zhou MM, (2010) Keeping it in the family: diverse histone recognition by conserved structural folds. Crit Rev Biochem Mol Biol 45: 488-505.
7. Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, et al. (2006) Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125: 467-481.
8. Cloos PA, Christensen J, Agger K, Maiolica A, Rappsilber J, et al. (2006) The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442: 307-311.
9. Klose RJ, Yamane K, Bae Y, Zhang D, Erdjument-Bromage H, et al. (2006) The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 442: 312-316.
10. Fodor BD, Kubicek S, Yonezawa M, O'Sullivan RJ, Sengupta R, et al. (2006) Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev 20: 1557-1562.
11. Shin S, Janknecht R, (2007) Diversity within the JMJD2 histone demethylase family. Biochem Biophys Res Commun 353: 973-977.
12. Trojer P, Zhang J, Yonezawa M, Schmidt A, Zheng H, et al. (2009) Dynamic Histone H1 Isotype 4 Methylation and Demethylation by Histone Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins. J Biol Chem 284: 8395-8405.
13. Shin S, Janknecht R, (2007) Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem Biophys Res Commun 359: 742-746.
14. Kouzarides T, (2007) Chromatin modifications and their function. Cell 128: 693-705.
15. Iwamori N, Zhao M, Meistrich ML, Matzuk MM, (2011) The testis-enriched histone demethylase, KDM4D, regulates methylation of histone H3 lysine 9 during spermatogenesis in the mouse but is dispensable for fertility. Biol Reprod 84: 1225-1234.
16. Subramanian K, Jia D, Kapoor-Vazirani P, Powell DR, Collins RE, et al. (2008) Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol Cell 30: 336-347.
17. Gaughan L, Stockley J, Wang N, McCracken SR, Treumann A, et al. (2011) Regulation of the androgen receptor by SET9-mediated methylation. Nucleic Acids Res 39: 1266-1279.
18. Li Y, Reddy MA, Miao F, Shanmugam N, Yee JK, et al. (2008) Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 283: 26771-26781.
19. Yang XD, Huang B, Li M, Lamb A, Kelleher NL, et al. (2009) Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J 28: 1055-1066.
20. Masatsugu T, Yamamoto K, (2009) Multiple lysine methylation of PCAF by Set9 methyltransferase. Biochem Biophys Res Commun 381: 22-26.
21. Kouskouti A, Scheer E, Staub A, Tora L, Talianidis I, (2004) Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell 14: 175-182.
22. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, et al. (2004) Regulation of p53 activity through lysine methylation. Nature 432: 353-360.
23. Huang J, Perez-Burgos L, Placek BJ, Sengupta R, Richter M, et al. (2006) Repression of p53 activity by Smyd2-mediated methylation. Nature 444: 629-632.
24. Shi X, Kachirskaia I, Yamaguchi H, West LE, Wen H, et al. (2007) Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol Cell 27: 636-646.
25. Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, et al. (2007) p53 is regulated by the lysine demethylase LSD1. Nature 449: 105-108.
26. Shin S, Janknecht R, (2007) Concerted activation of the Mdm2 promoter by p72 RNA helicase and the coactivators p300 and P/CAF. J Cell Biochem 101: 1252-1265.
27. Rossow KL, Janknecht R, (2003) Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300. Oncogene 22: 151-156.
28. Kim TD, Shin S, Janknecht R, (2008) Repression of Smad3 activity by histone demethylase SMCX/JARID1C. Biochem Biophys Res Commun 366: 563-567.
29. Kim J, Shin S, Subramaniam M, Bruinsma E, Kim TD, et al. (2010) Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10. Biochem Biophys Res Commun 401: 412-416.
30. Goel A, Janknecht R, (2004) Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu. J Biol Chem 279: 14909-14916.
31. Papoutsopoulou S, Janknecht R, (2000) Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300. Mol Cell Biol 20: 7300-7310.
32. Knebel J, de Haro L, Janknecht R, (2006) Repression of transcription by TSGA/Jmjd1a, a novel interaction partner of the ETS protein ER71. J Cell Biochem 99: 319-329.
33. Goel A, Janknecht R, (2003) Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol Cell Biol 23: 6243-6254.
34. Wu J, Janknecht R, (2002) Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A. J Biol Chem 277: 42669-42679.
35. Dowdy SC, Mariani A, Janknecht R, (2003) HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81. J Biol Chem 278: 44377-44384.
36. Bosc DG, Goueli BS, Janknecht R, (2001) HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene 20: 6215-6224.
37. Rossow KL, Janknecht R, (2001) The Ewing's sarcoma gene product functions as a transcriptional activator. Cancer Res 61: 2690-2695.
38. de Haro L, Janknecht R, (2002) Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter. Nucleic Acids Res 30: 2972-2979.
39. Janknecht R, (2001) Cell type-specific inhibition of the ETS transcription factor ER81 by mitogen-activated protein kinase-activated protein kinase 2. J Biol Chem 276: 41856-41861.
40. Bosc DG, Janknecht R, (2002) Regulation of HER2/Neu promoter activity by the ETS transcription factor, ER81. J Cell Biochem 86: 174-183.
41. Goueli BS, Janknecht R, (2003) Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. Oncogene 22: 8042-8047.
42. Shin S, Bosc DG, Ingle JN, Spelsberg TC, Janknecht R, (2008) Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors. J Cell Biochem 105: 866-874.
43. Kim TD, Shin S, Berry WL, Oh S, Janknecht R, (2012) The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells. J Cell Biochem 113: 1368-1376.
44. de Haro L, Janknecht R, (2005) Cloning of the murine ER71 gene (Etsrp71) and initial characterization of its promoter. Genomics 85: 493-502.
45. Mooney SM, Grande JP, Salisbury JL, Janknecht R, (2010) Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. Biochemistry 49: 1-10.
46. Janknecht R, (2003) Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1). Oncogene 22: 746-755.
47. Goueli BS, Janknecht R, (2004) Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2/Neu, Ras, or Raf. Mol Cell Biol 24: 25-35.
48. Shin S, Rossow KL, Grande JP, Janknecht R, (2007) Involvement of RNA helicases p68 and p72 in colon cancer. Cancer Res 67: 7572-7578.
49. Shin S, Kim TD, Jin F, van Deursen JM, Dehm SM, et al. (2009) Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81. Cancer Res 69: 8102-8110.
50. Mooney SM, Goel A, D'Assoro AB, Salisbury JL, Janknecht R, (2010) Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase. J Biol Chem 285: 30443-30452.
51. Riley T, Sontag E, Chen P, Levine A, (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412.
52. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, et al. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501.
53. Weiss T, Hergeth S, Zeissler U, Izzo A, Tropberger P, et al. (2010) Histone H1 variant-specific lysine methylation by G9a/KMT1C and Glp1/KMT1D. Epigenetics Chromatin 3: 7.
54. Parseghian MH, Newcomb RL, Winokur ST, Hamkalo BA, (2000) The distribution of somatic H1 subtypes is non-random on active vs. inactive chromatin: distribution in human fetal fibroblasts. Chromosome Res 8: 405-424.
55. Kuzmichev A, Jenuwein T, Tempst P, Reinberg D, (2004) Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell 14: 183-193.
56. Daujat S, Zeissler U, Waldmann T, Happel N, Schneider R, (2005) HP1 binds specifically to Lys26-methylated histone H1.4, whereas simultaneous Ser27 phosphorylation blocks HP1 binding. J Biol Chem 280: 38090-38095.
57. Vazquez A, Bond EE, Levine AJ, Bond GL, (2008) The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 7: 979-987.
58. Yang ZQ, Imoto I, Fukuda Y, Pimkhaokham A, Shimada Y, et al. (2000) Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res 60: 4735-4739.
59. Italiano A, Attias R, Aurias A, Perot G, Burel-Vandenbos F, et al. (2006) Molecular cytogenetic characterization of a metastatic lung sarcomatoid carcinoma: 9p23 neocentromere and 9p23 approximately p24 amplification including JAK2 and JMJD2C. Cancer Genet Cytogenet 167: 122-130.
60. Ehrbrecht A, Müller U, Wolter M, Hoischen A, Koch A, et al. (2006) Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components. J Pathol 208: 554-563.
61. Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, et al. (2009) Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 41: 465-472.
62. Liu G, Bollig-Fischer A, Kreike B, van de Vijver MJ, Abrams J, et al. (2009) Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene 28: 4491-4500.
63. Kawazu M, Saso K, Tong KI, McQuire T, Goto K, et al. (2011) Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS One 6: e17830.
64. Yang J, Jubb AM, Pike L, Buffa FM, Turley H, et al. (2010) The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. Cancer Res 70: 6456-6466.
65. Shi L, Sun L, Li Q, Liang J, Yu W, et al. (2011) Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc Natl Acad Sci USA 108: 7541-7546.
66. Spannhoff A, Hauser AT, Heinke R, Sippl W, Jung M, (2009) The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors. ChemMedChem 4: 1568-1582.
67. Smith EH, Janknecht R, Maher LJ, 3rd, (2007) Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma. Hum Mol Genet 16: 3136-3148.
68. Hamada S, Kim TD, Suzuki T, Itoh Y, Tsumoto H, et al. (2009) Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors. Bioorg Med Chem Lett 19: 2852-2855.
69. Rivlin N, Brosh R, Oren M, Rotter V, (2011) Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. Genes Cancer 2: 466-474.